权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Mechanisms Regulating B2AR Sorting to Signaling Microdomains

调节 B2AR 排序至信号微域的机制

基本信息

批准号：
10686148
负责人：
Ian Basil Chronis
金额：
$ 4.01万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-09-01 至 2024-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10686148
关键词：
Actins Agonist Alanine Binding Biological Assay Biosensor C-terminal Cardiac Myocytes Cardiovascular Diseases Catecholamines Cause of Death Cell membrane Cell surface Cells Complex Cyclic AMP-Dependent Protein Kinases Cysteine Data Drug Prescriptions Drug Targeting Drug usage Endosomes Fluorescence Microscopy Foundations G Protein-Coupled Receptor Signaling G-Protein-Coupled Receptors GTP-Binding Protein alpha Subunits, Gs GTP-Binding Proteins Gene Expression Profile Genes Genetic Genetic Transcription Goals Heart Heart failure Human Impairment Intracellular Membranes Label Ligands Measures Mediating Membrane Membrane Microdomains Microscopy Modeling Molecular Molecular Conformation Molecular Genetics Mutate Pathway interactions Pharmaceutical Preparations Phase Phosphorylation Play Post-Translational Protein Processing Process Proteins Receptor Activation Receptor Signaling Receptors, Adrenergic, beta-1 Recycling Regulation Research Resolution Role Serine Signal Transduction Signaling Protein Site Sorting Surface System Tail Testing Time Tubular formation United States Variant beta-2 Adrenergic Receptors cardioprotection clinically relevant experimental study extracellular functional improvement genetic regulatory protein heart function live cell microscopy new therapeutic target novel palmitoylation prevent protein complex receptor receptor recycling response serine receptor socioeconomics sorting nexins trafficking

项目摘要

PROJECT SUMMARY The beta 2 adrenergic receptor (B2AR) is a G Protein Coupled Receptor (GPCR) that plays a significant role in catecholamine signaling in the heart, especially during periods of heart failure. B2AR signaling in heart failure is incompletely understood, with contradictory data indicating both cardioprotective and deleterious impacts. It has become clear in recent years that changes in B2AR localization within the cell are major regulators of signaling and contribute to variation in response to differential stimulation at the same receptor. Once activated, B2AR can signal via the cognate G protein Gs at the cell surface and in intracellular endosomal compartments. The endosomal signaling promotes transcription of particular genes, most of which are not stimulated by B2AR activation at the plasma membrane. Gs activation by B2AR at endosomes is tightly controlled by posttranslational modifications of the B2AR C-terminal tail. Phosphorylation of serines 345 and 346 (SS345/6) on the receptor tail by protein kinase A (PKA) following agonist stimulation is required for B2AR sorting to specific tubular domains from which it can signal via Gs. PKA inhibition or mutating SS345/6 to alanine residues that cannot be phosphorylated prevents B2AR signaling from endosomes. These manipulations also increase the rate at which B2AR recycles to the plasma membrane by allowing the receptor to enter additional bulk recycling tubules which are unavailable to wild type B2AR and from which it cannot signal. The protein interactions governing this regulation are unknown. Phosphorylation of SS345/6 is also regulated by the presence of palmitoylation at B2AR cysteine 341. Abolition of palmitoylation at this site results in a significant increase in basal SS345/6 phosphorylation in the absence of agonist stimulation. This proposal tests the role of specific protein complexes in localizing B2AR to specific intracellular membrane domain, the role of phosphorylation and palmitoylation in this localization, and the functional relevance of this localization to signaling in the heart. I will use fluorescence microscopy and quantitative real-time PCR to determine the impact of candidate proteins on B2AR sorting to endosomal microdomains and signaling from these compartments in both HEK293 cells and primary cardiomyocytes. I will also use novel unbiased proximity labeling approaches to identify and quantify transient interactions of regulatory proteins with wild type, phosphorylation-deficient, and palmitoylation-deficient B2AR. The role of palmitoylation in regulating this process will be examined using functional genetics and microscopy with conformational biosensors that can identify both B2AR localization and signaling. The proposed research, by characterizing pathways with significant impact on the function of cardiomyocytes, will potentially identify new druggable targets that improve the function of the failing heart and alleviate heart failure.

项目总结